|
Covariates
|
Training cohort (n = 200)
|
Testing cohort (n = 199)
|
TCGA cohort (n = 399)
|
P-value
|
|---|
|
Age, no (%)
| | | | |
|
Young (≤ 65)
|
74 (37%)
|
85 (42.71%)
|
159 (39.85%)
|
0.2876
|
|
Old (> 65)
|
126 (63%)
|
114 (57.29%)
|
240 (60.15%)
| |
|
Gender, no (%)
| | | | |
|
Female
|
57 (28.5%)
|
48 (24.12%)
|
105 (26.32%)
|
0.3791
|
|
Male
|
143 (71.5%)
|
151 (72.88%)
|
294 (73.68%)
| |
|
Grade, no (%)
| | | | |
|
High Grade
|
189 (94.5%)
|
187 (93.97%)
|
376 (94.24%)
|
0.8185
|
|
Low Grade
|
9 (4.5%)
|
11 (5.53%)
|
20 (5.01%)
| |
|
Unknown
|
2 (1%)
|
1 (0.5%)
|
3 (0.75%)
| |
|
Stage, no (%)
| | | | |
|
Stage II
|
64 (32%)
|
62 (31.16%)
|
126 (31.58%)
|
0.9413
|
|
Stage III–IV
|
135 (67.5%)
|
136 (68.34%)
|
271 (67.92%)
| |
|
Unknown
|
1 (0.5%)
|
1 (0.5%)
|
2 (0.5%)
| |
|
T, no (%)
| | | | |
|
T2
|
62 (31%)
|
55 (27.64%)
|
117 (29.32%)
|
0.5967
|
|
T3–4
|
123 (61.5%)
|
126 (63.32%)
|
249 (62.41%)
| |
|
Unknown
|
15 (7.5%)
|
18 (9.05%)
|
33 (8.27%)
| |
|
M, no (%)
| | | | |
|
M0
|
89 (44.5%)
|
103 (51.76%)
|
192 (48.12%)
|
0.8268
|
|
M1
|
6 (3%)
|
5 (2.51%)
|
11 (2.76%)
| |
|
Unknown
|
105 (52.5%)
|
91 (45.73%)
|
196 (49.12%)
| |
|
N, no (%)
| | | | |
|
N0
|
120 (60%)
|
113 (56.78%)
|
233 (58.4%)
|
0.872
|
|
N1–3
|
63 (31.5%)
|
63 (31.66%)
|
126 (31.58%)
| |
|
Unknown
|
17 (8.5%)
|
23 (11.56%)
|
40 (10.03%)
| |
|
Fustat, no (%)
| | | | |
|
Alive
|
114 (57%)
|
109 (54.77%)
|
223 (55.89%)
|
0.7286
|
|
Dead
|
86 (43%)
|
90 (45.23%)
|
176 (44.11%)
| |
